Analysis of potential risks of clinical application of Yi Dian Hong and its proprietary Chinese medicines: A review

Author:

Chen Gongzhen1,Mao Leiming2,Xia Huyan1,Zhu Lei1,Huang Jiamin1,Lu Yingmin1,Liu Xin3ORCID,Tang Ting1

Affiliation:

1. First Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guizhou, China

2. Guiyang Second People’s Hospital, Guizhou, China.

3. Guizhou University of Traditional Chinese Medicine, Guizhou, China

Abstract

Yi Dian Hong, belonging to the Asteraceae family, finds widespread use in traditional Chinese medicine for its effectiveness in clearing heat, detoxifying, promoting blood circulation, reducing swelling, and cooling the blood. Modern medical research has revealed that Yi Dian Hong and its proprietary Chinese medicines possess biological functions such as inhibiting tumor-specific angiogenesis and regulating immune-related molecules. However, studies have identified that the primary component of Yi Dian Hong contains pyrrolizidine alkaloids (PAs), a toxic substance with potential risks to the liver, lungs, genes, and a propensity for carcinogenicity. Many countries impose strict controls on the content of PAs in herbal medicines and products. Unfortunately, China currently lacks relevant content standards, thereby introducing greater clinical application risks. To ensure the safety of clinical use of Yi Dian Hong, this review will analyze the risk associated with Yi Dian Hong and its proprietary Chinese medicines in clinical applications based on the PAs content in these medicines and provide recommendations.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference41 articles.

1. Progress in the study of chemical composition and pharmacological effects of Yi Dian Hong.;Danni;Proprietary Chin Med,2019

2. Dictionary of Traditional Chinese Medicine [M].;Guoping;Dictionary Tradit Chin Med,2006

3. Studies on the chemical constituents of the above-ground parts of Ajisai Hong.;Shoumao;Chin J Tradit Chin Med,2012

4. Potential risk assessment of pyrrolizidine alkaloid-containing proprietary Chinese medicines.;Xiong;Chinese Herbal Med,2021

5. Pyrrolizidine alkaloid-containing toxic plants (Senecio, Crotalaria, Cynoglossum, Amsinckia, Heliotropium, and Echium spp)[J/ OL] The Veterinary Clinics of North America.;Stegelmeier;Food Animal Practice,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3